Exploring Learnings From Translational & Clinical Development of Dolaflexin & Dolasynthen ADCs
Time: 5:00 pm
day: Day One PM
Details:
- Contrasting and sharing pre-clinical and clinical data for Dolaflexin and Dolasynthen ADCs, employing the same payload and same antibody
- Predicting and evaluating differences in clinical efficacy and tolerability performance based on preclinical data – what are the core lessons?
- Breaking down how differences in ADC design impact clinical performance
